Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) came out with a quarterly loss of $0.50 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.42 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this molecular diagnostics company would post a loss of $0.53 per share when it actually produced a loss of $0.27, delivering a surprise of 49.06%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Exact Sciences, whi ...